Global Health Financing: How Private Capital Risks Socializing Losses & Privatizing Control
Nairobi – For decades, global health funding operated on a relatively straightforward model: wealthy nations provided grants to poorer ones to address healthcare needs. Now, that system is undergoing a significant shift, with donors increasingly favoring approaches that leverage private capital through tools like guarantees and blended finance. This transition, however, is raising concerns about a potential distortion of risk, potentially socializing losses while allowing private entities to reap the profits.
A Shift Away From Traditional Grants
The established grant-based system, while imperfect, prioritized services delivered and lives saved over strict financial returns. However, official development assistance (ODA) for health has stagnated since the late 2010s, despite growing global needs. The existing system often relies on “vertical” health programs – focused on specific objectives – which can fragment health systems rather than strengthening them overall.
The Rise of “Catalytic Capital” and its Risks
Development-finance institutions are now promoting the concept of “catalytic capital,” aiming to mobilize larger sums of money without requiring increased public funding. This often involves “additionality ratios” – claims that every $1 of public money attracts $5 from private sources – particularly in health-related investments. However, critics argue this new architecture fundamentally alters the risk landscape.
Guarantees, for example, involve public or philanthropic entities stepping in to cover losses if private investors default on loans. While this lowers the cost of capital for projects deemed socially valuable, it also means donors are committing to potential obligations when economic conditions worsen. These shocks – including currency fluctuations, political instability and weak demand – are common in lower-income countries, increasing the likelihood of payouts.
Impact on Vaccine Manufacturing and Healthcare Priorities
The shift in risk is particularly evident in sectors like vaccine manufacturing. Guarantees can encourage local production, a public good, especially in regions like Africa, which currently imports over 99% of its vaccines. However, vaccine demand is unpredictable, and guarantees often extend for years to cover risks like fluctuating demand or exchange rate losses. When demand decreased after the COVID-19 pandemic, the financial burden shifted to the public entities that had initially underwritten the risk.
This emphasis on financial viability can also skew investment towards revenue-generating services – such as urban hospitals and specialized care – at the expense of more cost-effective, but lower-margin, investments in primary care, worker salaries, and rural clinics. A significant portion of private health investment in low-income countries has already been directed towards hospitals and specialized facilities.
Political and Systemic Constraints
the biggest obstacles to global health aren’t necessarily financial, but political. Guarantees cannot overcome weak tax bases, high debt burdens, or a lack of trust in public institutions. Low-income countries are now spending more on servicing external debt than on public health, a challenge that no amount of financial leverage can resolve. Governments may underinvest in health even when capital is available, prioritizing areas like security and infrastructure that offer more immediate political benefits.
What Could Happen Next
donors will continue to prioritize private capital mobilization, potentially expanding the use of guarantees and blended finance instruments. This could lead to increased private sector involvement in global health, but also a greater risk of unsustainable debt burdens for recipient countries. Alternatively, a reassessment of the current approach could occur, leading to a renewed focus on grant-based funding and strengthening domestic resource mobilization in low- and middle-income countries. Analysts expect that the effectiveness of these new financial instruments will be closely scrutinized in the coming years.
Frequently Asked Questions
What is “catalytic capital”?
“Catalytic capital” refers to the use of financial tools, like guarantees and blended finance, to attract larger amounts of private investment into development projects, including those in the health sector.
What are the potential downsides of using guarantees?
Guarantees can shift the risk of project failure from private investors to public or philanthropic entities, potentially leading to significant financial obligations for donors when economic conditions worsen in recipient countries.
What is the current state of ODA for health?
Official development assistance (ODA) for health has stagnated, in real terms, since the late 2010s, despite increasing global health needs.
As global health financing evolves, will these new approaches truly strengthen health systems, or will they simply shift the burden of risk onto those least equipped to bear it?